Finding an experienced doctor and hospital for prostate cancer treatment requires extensive research, evaluation, and an in-depth knowledge of your needs. This comprehensive guide will assist in the selection process while offering advice to avoid complications that could arise along the way.
Urologists are medical professionals specializing in diseases affecting the urinary tract. This includes treating issues related to prostate, kidneys and bladder.
Dr. Ash Tewari
Ashutosh Tewari, MD is an internationally-recognized board-certified urologist in NYC and leading prostate cancer researcher. He has made important contributions to robotic prostatectomy research while running one of the busiest clinical practices. Ashutosh has received research grants from both National Institutes of Health and US Department of Defense; moreover he has published more than 250 peer-reviewed scientific papers regarding prostate cancer and robotic surgery.
Tewari serves as Director of the Lefrak Center for Robotic Prostate Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and is widely acknowledged for his expertise in robotic prostate cancer surgery, having performed over 2,000 cases since 2003. A member of American Urological Association, Tewari has written many scientific articles. In 2012 he won the Gold Cystoscope Award, given annually to those urologists who have made significant advancements to their fields within 10 years after graduating residency training.
Although prostate cancer cannot be cured, prompt treatment can lengthen life and improve quality of life for those living with it. Therefore, finding an experienced urologist who can deliver maximum results should be your top priority when selecting one – their training and education are equally as crucial in this decision making process; an ideal doctor would have completed medical school and undergone rigorous postgraduate training programs before becoming available for practice.
Prostate cancer is an increasingly dangerous and common form of male illness that impacts men of all ages. Left untreated, prostate cancer can lead to severe symptoms and may even result in death – making early detection vitally important in order to provide appropriate care and treatments. As such, finding a surgeon capable of early diagnosis is key in order to ensuring an early and comprehensive approach towards care is taken for optimal results.
Hormone-blocking drugs and surgery are two effective prostate cancer treatments. Both approaches can significantly decrease risk and increase quality of life for their respective patients. There are other available treatment options such as radiation and chemotherapy therapy; see here.
As is well known, there are multiple forms of prostate cancer and each has a distinct treatment and prognosis plan. Before making any decisions regarding prostate cancer treatment options for yourself or a loved one, it is recommended to speak to an experienced urologist first.
Dr. Tanya Dorff
Dr. Tanya Dorff is an Associate Clinical Professor of Medical Oncology & Therapeutics Research and Head of Genitourinary Disease Program at City of Hope in Duarte, CA. Her clinical and translational research interests span novel immune-based strategies like Chimeric Antigen Receptor T Cell therapy as well as genomic/immunological differences among diverse prostate cancer populations. Additionally she sits on both National Comprehensive Cancer Network Prostate Cancer Guidelines Committee as well as co-chairing SWOG Genitourinary Cancer Committee
At the 2022 GU ASCO annual meeting, Dr. Dorff highlighted new targets in metastatic prostate cancer beyond PSMA such as KLK2 CAR T and JNJ-75229414 (a KLK2 inhibitor). Here she discusses these exciting developments for advanced prostate cancer and their possible impacts on treatment landscape in the future. In an interview with Alicia Morgans, Dr. Dorff highlights these advances further and how they might shape treatment choices going forward.
Alicia Morgans: 2017 has seen remarkable progress in treating prostate cancer, particularly among patients at more advanced stage disease. What have been some of the key advances?
Tanya Dorff: One of the major advances was the combination of poly-adenine diphosphate ribose polymerase (PARP) inhibitors with androgen receptor pathway inhibitors to develop PARP-PARP combination therapies – such as PROpel, MAGNITUDE and TALAPRO-2 trials which resulted in FDA approvals of these combination therapies for first-line metastatic castration-resistant prostate cancer patients. This has marked an unprecedented improvement in patient care while potentially leading to even further breakthroughs when combined with immunotherapy agents.
Another major breakthrough in advanced prostate cancer care is the advent of new medications like Abiraterone and Enzalutamide, recently shown to be effective against certain cases of Homology Recombination Repair Deficient Prostate Cancer (mCRPC). I’m eager to see how these agents will be combined with others in treating more men suffering from advanced prostate cancer.
Recent research conducted by the i3 Health team demonstrated that hot flashes associated with hormone therapy could be reduced significantly in men living with prostate cancer through oral medication, providing much-needed relief to those affected. This would provide them with improved quality of life.
Dr. James Wysock
James Wysock is an Urologist in New York, New York who specializes in prostate cancer treatment and comes highly rated by patients. He has published many articles in peer-reviewed journals as well as participated in clinical research studies that keep him abreast of advancements for treating his patients.
Dr. Wysock and his colleagues recently conducted a clinical trial using the ClariCore Optical Biopsy system, enabling more accurate prostate biopsy results and decreasing false positives and unnecessary biopsies. Furthermore, this device may serve to screen men for prostate cancer before providing guidance towards finding appropriate treatments options.
Dr. James Wysock of New York, New York and is affiliated with NYC Health + Hospitals/Coney Island and NYU Langone. He has earned professional recognition and awards over his 18 year practice period focusing on general surgery, urologic oncology and surgical oncology (cancer surgery). Dr. Wysock graduated from Northwestern University Feinberg School of Medicine.
He is accepting new patients and accepts several insurance plans such as Aetna, Blue Cross Blue Shield, and Cigna. In addition, there are telehealth appointments available.
Dr. Wysock has conducted extensive research on the use of iPS cell technology for treating various diseases, and on robotic kidney transplantation technology development. Additionally, he has written several articles regarding the role robots have in healthcare as well as benefits associated with using iPS cells.
At NYU Langone Health, he oversees the Division of Urology. Alongside administrative duties, he’s involved in educational and research projects – such as ongoing iPS cell characterization and transplantation projects – he is also an active member of both American College of Surgeons and American Association of Genitourinary Surgeons; when not at work he can often be found playing basketball or tennis!
Dr. Amy Krambeck
Dr. Amy Krambeck is a world-class surgeon providing expert urological care. With over two decades of experience and board certification in Urology, she serves Northwestern Memorial Hospital and IU Health Methodist Hospital patients as an affiliate and has presented at various national conferences. Additionally, she belongs to various professional organizations and societies.
She has extensive experience treating BPH and prostate cancer. She has undergone multiple surgical procedures, such as robotic prostatectomy – which involves extracting the prostate gland along with its surrounding structures – as well as managing other urological conditions, such as kidney stones and urinary tract infections. Furthermore, she is deeply committed to improving patient-centric care while increasing outcomes.
One of the key attributes to look out for when selecting a good prostate doctor is experience. The more surgeries they have performed, the greater their chance is of being able to detect and treat your condition effectively. Therefore, it is wise to find one who specializes specifically in prostate surgery as this will increase their ability. You should also take into account their length of practice.
Find a urologist with a multidisciplinary team of doctors. These professionals work together to ensure their patients receive top care, helping you select an ideal treatment option while making sure the procedure goes as smoothly and safely as possible.
If you are contemplating radical prostatectomy, it is crucial that you understand its risks. Among them may be temporary urine leakage, incontinence and pain; most will go away over time as your body heals itself. You may also experience reduced erection post-surgery; these side effects should only last up to three months.
If you live near New York and are seeking a prostate specialist, there are various options available to you. From local urologists who specialize in prostate cancer to visiting Mayo Clinic’s highly experienced staff – which offers second opinions – there are various choices.
